31722-293-01 |
31722-293 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
100 TABLET in 1 BOTTLE (31722-293-01) |
31722-293-10 |
31722-293 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
1000 TABLET in 1 BOTTLE (31722-293-10) |
31722-293-30 |
31722-293 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
30 TABLET in 1 BOTTLE (31722-293-30) |
31722-293-90 |
31722-293 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
90 TABLET in 1 BOTTLE (31722-293-90) |
31722-294-01 |
31722-294 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
100 TABLET in 1 BOTTLE (31722-294-01) |
31722-294-10 |
31722-294 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
1000 TABLET in 1 BOTTLE (31722-294-10) |
31722-294-30 |
31722-294 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
30 TABLET in 1 BOTTLE (31722-294-30) |
31722-294-90 |
31722-294 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
90 TABLET in 1 BOTTLE (31722-294-90) |
31722-295-01 |
31722-295 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
100 TABLET in 1 BOTTLE (31722-295-01) |
31722-295-10 |
31722-295 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
1000 TABLET in 1 BOTTLE (31722-295-10) |
31722-295-30 |
31722-295 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
30 TABLET in 1 BOTTLE (31722-295-30) |
31722-295-90 |
31722-295 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
90 TABLET in 1 BOTTLE (31722-295-90) |
43602-417-10 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
1000 TABLET in 1 BOTTLE (43602-417-10) |
43602-417-30 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
30 TABLET in 1 BOTTLE (43602-417-30) |
43602-417-90 |
43602-417 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.025 mg/1 |
90 TABLET in 1 BOTTLE (43602-417-90) |
43602-418-10 |
43602-418 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.05 mg/1 |
1000 TABLET in 1 BOTTLE (43602-418-10) |
43602-418-30 |
43602-418 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.05 mg/1 |
30 TABLET in 1 BOTTLE (43602-418-30) |
43602-418-90 |
43602-418 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.05 mg/1 |
90 TABLET in 1 BOTTLE (43602-418-90) |
43602-419-10 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
1000 TABLET in 1 BOTTLE (43602-419-10) |
43602-419-30 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
30 TABLET in 1 BOTTLE (43602-419-30) |